In conversation with e4m’s Brij Pahwa, Quick Heal CMO Sudhanshu Tripathi, discusses the rising tide of AI-driven cyber ...

OS Therapies Inc. ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today reported full-year 2024 financial results ended ...

Traditional EDR reacts to threats as they occur, but PEP takes a proactive stance. By leveraging techniques like Preemptive ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection ...